Πλοήγηση ανά Θέμα "chronic obstructive lung disease"
Αποτελέσματα 21-40 από 92
-
Comparable or higher prevalence of comorbidities in antiphospholipid syndrome vs rheumatoid arthritis: A multicenter, case-control study
(2021)Objectives: Evidence on comorbidity prevalence in antiphospholipid syndrome (APS) and its difference from high comorbidity burden rheumatic diseases is limited. Herein, we compare multiple comorbidities between APS and RA. ... -
COPD characteristics and socioeconomic burden in Hellenic correctional institutions
(2016)Background: The high prevalence of smoking (80%) in Greek correctional institutions is anticipated to result in high prevalence of COPD in such settings. Aim: The aim of the Greek obstructive luNg disease epidemiOlogy and ... -
COPD patients’ medical care and support in Greece during financial crisis
(2016)Background: The need to follow a multidisciplinary strategy in chronic obstructive pulmonary disease (COPD) management and rehabilitation in community settings in Greece raises significant questions, given the severe ... -
Diagnosis and management of chronic obstructive pulmonary disease by primary health care physicians
(2001)OBJECTIVE: The purpose of this study was the evaluation of the role of primary health care physicians in the diagnosis and management of chronic obstructive pulmonary disease (COPD)). METHOD: Sixty-five primary care ... -
Disease management knowledge is poor in Greek patients with chronic obstructive pulmonary disease before entering pulmonary rehabilitation: A qualitative study
(2022)INTRODUCTION Patient knowledge on important self-management topics of COPD is low. Education component of pulmonary rehabilitation may increase knowledge, facilitate health behavior change and improve self-efficacy. The ... -
Do the Kinetics of Antibody Responses Predict Clinical Outcome in Hospitalized Patients With Moderate-to-Severe COVID-19?
(2022)Background/Aim: The relationship between the kinetics of antibody responses to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the severity of Coronavirus Disease 2019 (COVID-19) is poorly understood. The ... -
Does Turning Affect Shuttle Walking Test Performance in Cardiovascular Disease Patients? A Narrative Review
(2021)Objective: To critically present and discuss the influences of turning on incremental shuttle walking test (ISWT) performance in clinically stable patients with cardiovascular disease (CVD). Methods: We searched the ... -
Early COVID-19 lockdown in Greece and idiopathic pulmonary fibrosis: a beneficial “impact” beyond any expectation
(2021)[No abstract available] -
Editorial: Nicotine and SARS-CoV-2: COVID-19 may be a disease of the nicotinic cholinergic system
(2020)[No abstract available] -
Effect of PM2.5 Levels on ED Visits for Respiratory Causes in a Greek Semi-Urban Area
(2022)Fine particulate matter that have a diameter of <2.5 μm (PM2.5) are an important factor of anthropogenic pollution since they are associated with the development of acute respiratory illnesses. The aim of this prospective ... -
Effects of varenicline therapy in combination with advanced behavioral support on smoking cessation and quality of life in inpatients with acute exacerbation of COPD, bronchial asthma, or community-acquired pneumonia: A prospective, open-label, preference-based, 52-week, follow-up trial
(2018)Quitting smoking is the most important element in the therapeutic management of chronic respiratory diseases. Combining pharmacotherapy with behavioral support increases smoking cessation success rates. In addition, ... -
Efficacy and safety of nintedanib in a greek multicentre idiopathic pulmonary fibrosis registry: A retrospective, observational, cohort study
(2020)Nintedanib is a tyrosine kinase inhibitor approved for the treatment of idiopathic pulmonary fibrosis (IPF). In a retrospective, real-world study across seven Greek hospitals, we evaluated the effectiveness and safety of ... -
Eight weeks unsupervised pulmonary rehabilitation in previously hospitalized of sars-cov-2 infection
(2021)The aim of our study was to determine the impact of unsupervised Pulmonary Rehabilitation (uns-PR) on patients recovering from COVID-19, and determine its anthropometric, biological, demographic and fitness correlates. All ... -
Elevated preoperative suPAR is a strong and independent risk marker for postoperative complications in patients undergoing major noncardiac surgery (SPARSE)
(2022)Background: Patients undergoing major surgery are often at risk of developing postoperative complications. We investigated whether a preoperative marker of chronic inflammation, soluble urokinase plasminogen activator ... -
Endovascular aneurysm repair in patients with a wide proximal aortic neck: A systematic review and meta-analysis of comparative studies
(2019)INTRODUCTION: The aim was to investigate the impact of wide proximal aortic diameter on outcome after standard endovascular repair (sEVAR) of infrarenal abdominal aortic aneurysms. EVIDENCE ACQUISITION: A systematic search ... -
Exhaled breath condensate in asthma: From bench to bedside
(2011)The need for non-invasive assessment of airway inflammation is imperative, since inflammatory airway diseases, such as asthma and COPD, are characterized by variation in their clinical presentation throughout their course. ... -
Exhaled Nitric Oxide (FeNO) in Patients Hospitalized for an Exacerbation of Bronchiectasis and/or COPD: FeNO Levels in COPD and Bronchiectasis
(2021)Exhaled nitric oxide (FeNO) represents an important marker of airway inflammation, yet its role in chronic obstructive pulmonary disease (COPD) and/or bronchiectasis is not well studied. We aimed to measure FeNO in patients ...